Transcription of MHRA PUBLIC ASSESSMENT REPORT
{{id}} {{{paragraph}}}
MHRA PUBLIC ASSESSMENT REPORT Controlling the risk of misuse of medicines containing pseudoephedrine and ephedrine July 2009 Executive summary 2 1. Introduction 4 2. Background 4 3. Amendment of legislation 5 4. Summary of implementation of measures 6 Pharmacy supervision plus education and awareness initiative 6 Pharmacy reporting of suspicions 6 Sales tracking and other measures to monitor evidence of use of OTC medicines in the manufacture of methylamphetamine 7 Triggers for a review of the availab
MHRA PUBLIC ASSESSMENT REPORT Controlling the risk of misuse of medicines containing pseudoephedrine and ephedrine July 2009 Executive summary 2
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}